Proton translocating ATPase mediated fungicidal activity of a novel complex carbohydrate: CAN-296

International Journal of Antimicrobial Agents

Volumn 13, Issue 4, 2000, Pages 287-295

  Ben Josef, A M ^a   Manavathu, E K ^a   Platt, D ^b   Sobel, J D ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b Safe Science   (United States)

Author keywords

Antifungal agent; Candida; Complex carbohydrate; Fungal infection; H+ ATPase

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CAN 296; FLUCONAZOLE; ITRACONAZOLE; PROTON PUMP; UNCLASSIFIED DRUG;

ACIDIFICATION; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KRUSEI; CONTROLLED STUDY; FUNGICIDAL ACTIVITY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTOPLAST; SACCHAROMYCES CEREVISIAE;

ADENOSINE TRIPHOSPHATE; ANTIFUNGAL AGENTS; CANDIDA; CELL MEMBRANE; CULTURE MEDIA; GLUCOSAMINE; GLUCOSE; HYDROGEN-ION CONCENTRATION; MICROBIAL SENSITIVITY TESTS; PROTON PUMPS; PROTON-TRANSLOCATING ATPASES; SACCHAROMYCES CEREVISIAE;

EID: 0033964016     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00140-5     Document Type: Article

References (39)

1. Bodey G.P. The emergence of fungi as major hospital pathogens. J. Hosp. Infect. 11:1988;411-426.
2. Banerjee S.N., Enori T.G., Culver D.H. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am. J. Med. 91(Suppl. 3B):1991;86S-89S.
3. Edwards J.R. Invasive Candida infections: evolution of a fungal pathogen. New Engl. J. Med. 324:1991;1060-1062.
4. Beck-Sague C.M., Jarvis W.R. The National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial infections in the United States, 1980-1990. J. Infect. Dis. 167:1993;1247-1251.
5. Pursell K.J., Telzak E.E., Armstrong D. Aspergillus species colonization and invasive disease in patients with AIDS. Clin. Infect. Dis. 14:1992;141-148.
6. Lortholary O., Meyohas M.C., Dupont B. et al. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. Am. J. Med. 95:1993;177-187.
7. Khoo S.H., Denning D.W. Invasive Aspergillosis in patients with AIDS. Clin. Infect. Dis. 19(Suppl. 1):1994;S41-S48.
8. Wallace M.R., Kanak R.J., Newton J.A. Invasive aspergillosis in patients with AIDS. Clin. Infect. Dis. 19:1994;222.
9. Talkoff-Rubin N.E., Rubin R.H. Opportunistic fungal and bacterial infections in the renal transplant recipient. J. Am. Soc. Nephrol. 2(Suppl. 3):1992;S264-S269.
10. Patel R., Paya C.V. Infections in solid-organ transplant recipients. Clin. Microbiol. Rev. 10:1997;86-124.
11. Pannuti C.S., Gingrich R.D., Pfaller M.A., Wenzel R.P. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. J. Clin. Oncol. 9:1991;77-84.
12. Paya C.V. Fungal infections in solid-organs transplantation. Clin. Infect. Dis. 16:1993;677-688.
13. Morrison V.A., Haake R.J., Weisdrof D.J. Non-candida fungal infections after bone marrow transplantation: risk factors and outcome. Am. J. Med. 9:1994;497-503.
14. Iwen P.C., Reed E.C., Armitage J.O. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem-cell transplants. Infect. Control Hosp. Epidemiol. 14:1993;131-139.
15. Wald A., Leisenring W., Van Burik J., Bowden R.A. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J. Infect. Dis. 175:1997;1459-1466.
16. Hutter R.V.P., Lieberman P.H., Collins H.S. Aspergillosis in a cancer hospital. Cancer. 17:1964;747-756.
17. Gerson S.L., Talbot G.H., Hurwitz S. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in acute leukemia. Arch. Intern. Med. 100:1984;345-351.
18. Wingard JR. Aspergillus infections in immunocompromised cancer patients. Intern Med, Aspergillus Spec Rep 1995;4-10.
19. Minamoto G.Y., Barlam T.F., Vander Els N.J. Invasive aspergillosis in patients with AIDS. Clin. Infect. Dis. 14:1992;66-74.
20. Sanglard D., Ischer F., Monod M., Bille J. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:1995;2378-2386.
21. White T.C., Marr K.A., Bowden R.A. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:1998;382-402.
22. Denning D.W., Venkateswarlu K., Oakley K.L. et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 41:1997;1364-1368.
23. Oakley K.L., Morrissey G., Denning D.W. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus. Antimicrob. Agents Chemother. 41:1997;1504-1507.
24. Rex J.H., Rinaldi M.G., Pfaller M.A. Resistance of Candida species to Fluconazole. Antimicrob. Agents Chemother. 39:1995;1-8.
25. Ben-Josef A.M., Manavathu E.K., Platt D., Sobel J.D. In vitro activity of CAN-296: a naturally occurring complex carbohydrate. J. Antibiot. 50:1997;171-177.
26. Moller J.V., Juul B., Le Maire M. Structural organization, ion transport, and energy transduction of P-type ATPases. Biochim. Biophys. Acta. 1286:1996;1-51.
27. Axelsen K.B., Palmgren M.G. Evolution of substrate specificities in the P-type ATPase superfamily. J. Mol. Evol. 46:1998;84-101.
28. Serrano R.M. Structure and function of proton translocating ATPase in plasma membranes of plants and fungi. Biochim. Biophys. Acta. 947:1988;1-28.
29. 2+-ATPase. Nature. 319:1986;689-693.
30. +-ATPase from Candida albicans. J. Bacteriol. 173:1991;6826-6836.
31. + translocation by the plasma membrane ATPase of Neurospora: studies on plasma membrane vesicles and reconstituted enzymes. J. Biol. Chem. 259:1984;7884-7892.
32. +-ATPase. Adv. Mol. Cell. Biol. 23A:1998;143-166.
33. Monk B.C., Mason A.B., Abramochkin G., Haber J.E., Seto-Young D., Perlin D.S. The yeast plasma membrane proton pumping ATPase is a viable antifungal target. I. Effects of the cysteine-modifying reagent omeprazole. Biochim. Biophys. Acta. 1239:1995;81-90.
34. Monk B.C., Perlin D.S. Fungal plasma membrane proton pumps as promising new antifungal targets. Crit. Rev. Microbiol. 20:1994;209-223.
35. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts, approved standard M27-A 1997. Villanova, PA: National Committee for Clinical Laboratory Standards.
36. +-ATPase of hygromycin B-resistant pma 1 mutants from Saccharomyces cerevisiae. J. Biol. Chem. 264:1989;21857-21864.
37. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
38. Ames B.N. Assay of inorganic phosphate, total phosphate and phosphatases. Methods Enzymol. 8:1986;115-118.
39. Ben-Josef A.M., Manavathu E.K., Platt D., Sobel J.D. Involvement of calcium inhibitable binding to the cell wall in the fungicidal activity of CAN-296. J. Antimicrob. Chemother. 44:1999;217-222.